Lea von Bidder
Showing 1–1 of 1 transcripts.
- Goldman Sachs27 min
The Future of ‘Femtech’
Ann Roberts, Lea von Bidder, Dr. Peter Kecskemethy, Antonia Riera, Allison Nathan, Leah Von Bitter
Flow Health CEO Anne Roberts, Ava co-founder Leah Von Bitter, and Chiron Medical founder Peter Ketch-Kometi led a strategic discussion on defining the Femtech sector through evidence-based science and rigorous regulation rather than consumer tech labels. The panelists detailed how their respective companies are leveraging machine learning and wearable physiology data to achieve massive scale, with Flow Health reporting 107% revenue growth and Ava successfully pivoting its algorithms for early COVID detection. While acknowledging the sector's unique capital challenges compared to fintech, the founders outlined future roadmaps focused on expanding product portfolios into menopause and contraception while pushing for AI-driven regulatory frameworks to enable broader clinical adoption.